Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000173099 | SCV000224183 | pathogenic | not provided | 2013-03-26 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001212193 | SCV001383769 | pathogenic | Peroxisome biogenesis disorder | 2019-05-30 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Ser232Hisfs*15) in the PEX6 gene. It is expected to result in an absent or disrupted protein product. This variant is not present in population databases (ExAC no frequency). This variant has been observed in individuals affected with Zellweger syndrome (PMID: 17041890, 19877282). ClinVar contains an entry for this variant (Variation ID: 92790). Loss-of-function variants in PEX6 are known to be pathogenic (PMID: 8670792, 19877282, 21031596). For these reasons, this variant has been classified as Pathogenic. |